Bio-Rad Laboratories ddPCR Microsatellite Instability (MSI) Assay

Friday, 19 July, 2019 | Supplied by: Bio-Rad Laboratories Pty Ltd



Bio-Rad’s ddPCR Microsatellite Instability (MSI) Assay can be completed in one day on a ddPCR-based platform to quantify the level of MSI present in colorectal tumours.

Using either a blood or FFPE sample, the RUO assay quantitatively identifies mutations in five loci that lead to identification of MSI status. Colorectal tumours that test positive for MSI-high are candidates for treatment with immune-checkpoint inhibitors.

Simple and sensitive, the assay provides a standardised output that does not require a pathologist’s interpretation. The test can use patient blood samples in the absence of tumour tissue and does not require matched normal tissue or normal blood samples.

Online: www.bio-rad.com
Phone: 02 9914 2800
Related Products

Phase Genomics Hi-C proximity ligation kits

Phase Genomics applies Hi-C and other proximity-ligation methods to enable chromosome-scale...

Mercodia Total GIP Northern Lights (NL)-ELISA

Mercodia's Total GIP NL-ELISA provides a chemiluminescent method for the quantitative...

Merck Plug & Play Upstream Development Service

Merck has launched its Plug & Play Upstream Development Service to help emerging biotech and...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd